COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

NASDAQ:CHCI • US2056842022

11.5 USD
0 (0%)
Last: Feb 20, 2026, 08:22 PM
Fundamental Rating

7

CHCI gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 62 industry peers in the Real Estate Management & Development industry. CHCI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CHCI has a decent growth rate and is not valued too expensively. These ratings could make CHCI a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • CHCI had positive earnings in the past year.
  • CHCI had a positive operating cash flow in the past year.
  • Each year in the past 5 years CHCI has been profitable.
  • In the past 5 years CHCI always reported a positive cash flow from operatings.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • CHCI's Return On Assets of 20.57% is amongst the best of the industry. CHCI outperforms 100.00% of its industry peers.
  • The Return On Equity of CHCI (24.71%) is better than 100.00% of its industry peers.
  • The Return On Invested Capital of CHCI (12.79%) is better than 98.39% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHCI is significantly above the industry average of 5.46%.
  • The 3 year average ROIC (18.89%) for CHCI is well above the current ROIC(12.79%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROIC 12.79%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 24.90%, CHCI belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
  • CHCI's Profit Margin has improved in the last couple of years.
  • CHCI has a better Operating Margin (16.59%) than 85.48% of its industry peers.
  • CHCI's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CHCI (21.37%) is comparable to the rest of the industry.
  • CHCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

  • CHCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CHCI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CHCI has more shares outstanding
  • CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CHCI has an Altman-Z score of 4.98. This indicates that CHCI is financially healthy and has little risk of bankruptcy at the moment.
  • CHCI's Altman-Z score of 4.98 is amongst the best of the industry. CHCI outperforms 82.26% of its industry peers.
  • CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.98
ROIC/WACC1.47
WACC8.72%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • CHCI has a Current Ratio of 3.95. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.95, CHCI belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
  • CHCI has a Quick Ratio of 3.95. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.95, CHCI belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.95
Quick Ratio 3.95
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

  • CHCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.43%, which is quite impressive.
  • Measured over the past years, CHCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.08% on average per year.
  • The Revenue has grown by 22.98% in the past year. This is a very strong growth!
  • Measured over the past years, CHCI shows a quite strong growth in Revenue. The Revenue has been growing by 15.18% on average per year.
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.65, the valuation of CHCI can be described as very reasonable.
  • Based on the Price/Earnings ratio, CHCI is valued cheaper than 91.94% of the companies in the same industry.
  • CHCI is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.65
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • CHCI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHCI is cheaper than 88.71% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CHCI is valued a bit cheaper than 77.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.52
EV/EBITDA 9.38
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • The excellent profitability rating of CHCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for CHCI!.
Industry RankSector Rank
Dividend Yield 0%

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (2/20/2026, 8:22:56 PM)

11.5

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-05
Earnings (Next)03-19
Inst Owners11.57%
Inst Owner Change11.71%
Ins Owners65.87%
Ins Owner Change0.3%
Market Cap116.03M
Revenue(TTM)55.84M
Net Income(TTM)13.90M
Analysts0
Price TargetN/A
Short Float %1.03%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.65
Fwd PE N/A
P/S 2.08
P/FCF 16.52
P/OCF 15.87
P/B 2.06
P/tB 2.07
EV/EBITDA 9.38
EPS(TTM)1.33
EY11.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.7
FCFY6.05%
OCF(TTM)0.72
OCFY6.3%
SpS5.53
BVpS5.58
TBVpS5.56
PEG (NY)N/A
PEG (5Y)0.14
Graham Number12.92
Profitability
Industry RankSector Rank
ROA 20.57%
ROE 24.71%
ROCE 16.19%
ROIC 12.79%
ROICexc 23.58%
ROICexgc 23.74%
OM 16.59%
PM (TTM) 24.9%
GM 21.37%
FCFM 12.58%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexgc growth 3Y10.99%
ROICexgc growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score6
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 91.11%
Cap/Sales 0.51%
Interest Coverage 250
Cash Conversion 76.32%
Profit Quality 50.51%
Current Ratio 3.95
Quick Ratio 3.95
Altman-Z 4.98
F-Score6
WACC8.72%
ROIC/WACC1.47
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)123.43%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%-77.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.98%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%2.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.59%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.03%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y17.9%
OCF growth 3Y11.03%
OCF growth 5Y4.91%

COMSTOCK HOLDING COMPANIES / CHCI FAQ

Can you provide the ChartMill fundamental rating for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a fundamental rating of 7 / 10 to CHCI.


What is the valuation status of COMSTOCK HOLDING COMPANIES (CHCI) stock?

ChartMill assigns a valuation rating of 5 / 10 to COMSTOCK HOLDING COMPANIES (CHCI). This can be considered as Fairly Valued.


What is the profitability of CHCI stock?

COMSTOCK HOLDING COMPANIES (CHCI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of COMSTOCK HOLDING COMPANIES (CHCI) stock?

The Price/Earnings (PE) ratio for COMSTOCK HOLDING COMPANIES (CHCI) is 8.65 and the Price/Book (PB) ratio is 2.06.


How financially healthy is COMSTOCK HOLDING COMPANIES?

The financial health rating of COMSTOCK HOLDING COMPANIES (CHCI) is 9 / 10.